课题基金 / 基金详情

项目摘要

项目成果

Laura S Levy的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):γ -逆转录病毒是一组哺乳动物致癌逆转录病毒,通常与自然宿主的长潜伏期白血病和淋巴瘤诱导相关。猫白血病病毒(FeLV)是一种自然产生的γ -逆转录病毒,在自然界中不是作为一个单一的基因组物种发现的,而是作为一个密切相关的遗传复杂的病毒家族。这种变异的结果是一个基因多样化的病毒种群,在体内不断受到选择压力的影响,并从中产生变异作为优势种。我们之前描述了FeLV的分离株,称为FeLV-945,在自然感染动物的地理集群中作为非t细胞疾病的优势物种。先前的研究表明FeLV-945独特的LTR和SU基因特征具有独特的生物学特性。这些序列元素被证明赋予病毒复制优势,改变与宿主细胞受体的相互作用,并作为一种新型疾病谱系的决定因素。研究提出了三个特定的目的,以确定其在感染和发病机制中的作用和作用机制。Aim 1提出确定FeLV-945独特的LTR和SU基因在自然宿主疾病判断中的作用。实验将确定FeLV-945 LTR是否在体内具有复制优势,以及FeLV-945 SU的受体结合特性如何影响疾病进展。目的2旨在探讨造血祖细胞初始凋亡危机的机制以及随后存活群体的出现。这些研究将利用早期造血祖细胞分化的组织培养模型来验证一个关于p53的作用及其在疾病过程早期抑制的新假设。目的3旨在研究感染在疾病早期改变造血祖细胞分化的机制。特别是,实验将集中于感染改变b淋巴样细胞分化的机制。
英文摘要
DESCRIPTION (provided by applicant): The gammaretroviruses represent a group of mammalian oncogenic retroviruses typically associated with the long-latency induction of leukemia and lymphoma in the natural host. Feline leukemia virus (FeLV), a naturally occurring gammaretrovirus, is found in nature not as a single genomic species but as a genetically complex family of closely related viruses. The consequence of this variation is a genetically diverse virus population that is continuously shaped by selective pressures in vivo and from which variants arise as predominant species. We previously described an isolate of FeLV, termed FeLV-945, as the predominant species in non-T-cell diseases in a geographic cluster of naturally infected animals. Previous studies demonstrated distinctive biological properties of the unique LTR and SU gene characteristic of FeLV-945. These sequence elements were shown to confer a replicative advantage to the virus, to alter interactions with the host cell receptor, and to act as determinants of a novel disease spectrum. Studies are proposed in three Specific Aims to determine their role and mechanisms of action in infection and pathogenesis. Aim 1 proposes to determine the roles of the unique LTR and SU gene of FeLV-945 in disease determination in the natural host. Experiments will be performed to determine whether the FeLV-945 LTR confers a replicative advantage in vivo, and how the receptor-binding properties of FeLV-945 SU influence disease progression. Aim 2 proposes to explore the mechanism of initial apoptotic crisis in hematopoietic progenitors and the subsequent emergence of a surviving population. These studies will utilize a tissue culture model of early hematopoietic progenitor cell differentiation to test a novel hypothesis about the role of p53 and its suppression early in the disease process. Aim 3 proposes to investigate the mechanisms by which infection alters the differentiation of hematopoietic progenitors early in the disease process. In particular, experiments will focus on the mechanism by which infection alters B-lymphoid cell differentiation. Relevance of the Project to Public Health: The proposed analysis of FeLV-mediated disease induction offers a rare opportunity to study mechanisms of pathogenesis in an outbred mammalian host during infection with a natural pathogen. Further, the proposed work is important for understanding the early stages of the induction of malignancy by examining the process in an animal model.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.
SL3-3 鼠白血病病毒感染早期癌前阶段的造血和胸腺生成受到破坏。
DOI: 10.1128/jvi.76.5.2363-2374.2002
发表时间: 2002
期刊: Journal of virology
影响因子: 5.4
作者: [Rulli,Karen, Lenz,Jack, Levy,LauraS]
通讯作者: Levy,LauraS
DOI: 10.1128/jvi.02119-16
发表时间: 2017-03-01
期刊: Journal of virology
影响因子: 5.4
作者: [Terry A, Kilbey A, Naseer A, Levy LS, Ahmad S, Watts C, Mackay N, Cameron E, Wilson S, Neil JC]
通讯作者: Neil JC
28th International Workshop on Retroviral Pathogenesis
  • 批准号:
    9189824
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2016
  • 负责人:
    Laura S Levy
  • 依托单位:
Selective Forces Operative in FeLV Infection
  • 批准号:
    7911087
  • 项目类别:
  • 资助金额:
    $25.42万
  • 财政年份:
    2009
  • 负责人:
    Laura S Levy
  • 依托单位:
IMMUNOBIOLOGY OF SAIDS-ASSOCIATED LYMPHOMAS
  • 批准号:
    7562246
  • 项目类别:
  • 资助金额:
    $7.16万
  • 财政年份:
    2007
  • 负责人:
    Laura S Levy
  • 依托单位:
IMMUNOBIOLOGY OF SAIDS-ASSOCIATED LYMPHOMAS
  • 批准号:
    7348971
  • 项目类别:
  • 资助金额:
    $6.54万
  • 财政年份:
    2006
  • 负责人:
    Laura S Levy
  • 依托单位:
海外基金